USD 0.03
(6.67%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 4.27 Million USD | -67.9% |
2022 | 13.32 Million USD | -18.78% |
2021 | 16.4 Million USD | 26.62% |
2020 | 12.95 Million USD | 53.82% |
2019 | 8.42 Million USD | 180.52% |
2018 | 3 Million USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 5.88 Million USD | 37.63% |
2024 Q2 | 5.21 Million USD | -11.46% |
2023 Q3 | 15.72 Million USD | 0.36% |
2023 FY | 4.27 Million USD | -67.9% |
2023 Q4 | 4.27 Million USD | -72.8% |
2023 Q2 | 15.67 Million USD | 4.91% |
2023 Q1 | 14.93 Million USD | 12.09% |
2022 Q3 | 14.59 Million USD | -4.64% |
2022 Q2 | 15.3 Million USD | -13.13% |
2022 Q1 | 17.62 Million USD | 7.39% |
2022 FY | 13.32 Million USD | -18.78% |
2022 Q4 | 13.32 Million USD | -8.69% |
2021 Q2 | 14.66 Million USD | 5.97% |
2021 FY | 16.4 Million USD | 26.62% |
2021 Q1 | 13.83 Million USD | 6.78% |
2021 Q4 | 16.4 Million USD | 9.66% |
2021 Q3 | 14.96 Million USD | 2.04% |
2020 Q2 | 12.26 Million USD | 17.28% |
2020 FY | 12.95 Million USD | 53.82% |
2020 Q1 | 10.45 Million USD | 24.16% |
2020 Q4 | 12.95 Million USD | 18.53% |
2020 Q3 | 10.93 Million USD | -10.88% |
2019 FY | 8.42 Million USD | 180.52% |
2019 Q4 | 8.42 Million USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2018 FY | 3 Million USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Biotricity, Inc. | 1.87 Million USD | -127.626% |
Cell MedX Corp. | - USD | -Infinity% |
Dynatronics Corporation | 5.59 Million USD | 23.525% |
Nemaura Medical Inc. | 1.75 Million USD | -143.781% |
PetVivo Holdings, Inc. | 390.07 Thousand USD | -996.709% |
RetinalGenix Technologies Inc. | - USD | -Infinity% |
Sonendo, Inc. | 11.07 Million USD | 61.369% |
Telesis Bio, Inc. | 4.02 Million USD | -6.286% |
Talis Biomedical Corporation | - USD | -Infinity% |
Viveve Medical, Inc. | 1.47 Million USD | -190.625% |